Eli Lilly and Zyprexa Under the Spotlight for criminal activity
2009 Report posted for filing Reviewed by John M. Grohol, Psy.D. on June 14, 2009 Eli Lilly & Co.’s atypical antipsychotic medication, Zyprexa, was not only marketed to doctors…
Corruption - Fabricated Data
Highlights
Ineffective Treatments
Lethal or Unintended Side Effects
Medical Ethics
Medical Propaganda
Eli Lilly and Zyprexa Under the Spotlight / (( Employees WROTE the MEDICAL STUDIES ))
Public release date: 16-Jun-2009 - was done despite Lilly’s access and knowledge of at least seven studies that showed the drug was apparently ineffective for the treatment of dementia -…
You must be logged in to post a comment.